JNJ Sep 2024 150.000 call
| Previous close | 7.39 |
| Open | 6.25 |
| Bid | 8.10 |
| Ask | 8.75 |
| Strike | 150.00 |
| Expiry date | 2024-09-20 |
| Day's range | 6.25 - 8.15 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.57k |
ReutersCancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies
A group of cancer victims sued Johnson & Johnson on Wednesday, accusing the healthcare company of committing fraud through repeated and continued efforts to use a shell company's bankruptcy to resolve tens of thousands of lawsuits alleging its talc products contained asbestos and caused cancer. Five plaintiffs who seek to represent over 50,000 people who have sued J&J over its talc products filed the proposed class action in New Jersey federal court. "Johnson & Johnson is playing a dark game of chess with this country's financial and judicial systems," said Mike Papantonio, an attorney for the cancer plaintiffs.
ZacksHow to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
GuruFocus.comJohnson & Johnson's Dividend Analysis
Johnson & Johnson (NYSE:JNJ) recently announced a dividend of $1.24 per share, payable on 2024-06-04, with the ex-dividend date set for 2024-05-20. Using the data from GuruFocus, let's delve into Johnson & Johnson's dividend performance and assess its sustainability. What Does Johnson & Johnson Do?
